Similar articles

• Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic.

  Dass CR, Choong PF. Dass CR, et al. Pharmazie. 2008 Jan;63(1):4-6. Pharmazie. 2008. PMID: 18271294 Review.
• Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.

  Streck CJ, Zhang Y, Zhou J, Ng C, Nathwani AC, Davidoff AM. Streck CJ, et al. J Pediatr Surg. 2005 Jan;40(1):236-43. doi: 10.1016/j.jpedsurg.2004.09.049. J Pediatr Surg. 2005. PMID: 15868591
• Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death.

  Imai D, Yoneya S, Gehlbach PL, Wei LL, Mori K. Imai D, et al. J Cell Physiol. 2005 Feb;202(2):570-8. doi: 10.1002/jcp.20155. J Cell Physiol. 2005. PMID: 15316929
• Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.

  Barnstable CJ, Tombran-Tink J. Barnstable CJ, et al. Prog Retin Eye Res. 2004 Sep;23(5):561-77. doi: 10.1016/j.preteyeres.2004.05.002. Prog Retin Eye Res. 2004. PMID: 15302351 Review.
• [Neuroprotective gene therapy to treat patients with retinitis pigmentosa].

  Ikeda Y, Ishibashi T. Ikeda Y, et al. Fukuoka Igaku Zasshi. 2010 Sep;101(9):183-9. Fukuoka Igaku Zasshi. 2010. PMID: 21226311 Review. Japanese. No abstract available.